Major Histocompatibility Complex (MHC) Class I Gene  Expression in Single Neurons of the Central Nervous System: Differential Regulation by Interferon (IFN)-γ and Tumor Necrosis Factor (TNF)-α by Neumann, H. et al.
 
305
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/97/01/305/12 $2.00
Volume 185, Number 2, January 20, 1997 305–316
 
Major Histocompatibility Complex (MHC) Class I Gene 
Expression in Single Neurons of the Central
Nervous System: Differential Regulation by
Interferon (IFN)-
 
g
 
 and Tumor Necrosis Factor (TNF)-
 
a
 
By H. Neumann, H. Schmidt, A. Cavalié, D. Jenne, and H. Wekerle
 
From the Department of Neuroimmunology, Max-Planck-Institute for Psychiatry, D-82152 
Martinsried, Germany
 
Summary
 
This study examined the effect of the pro-inflammatory cytokines interferon-
 
g
 
 (IFN-
 
g
 
) and
tumor necrosis factor-
 
a
 
 (TNF-
 
a
 
) on the induction of MHC class I–related genes in function-
ally mature brain neurons derived from cultures of dissociated rat hippocampal tissue. Patch
clamp electrophysiology combined with single cell RT-PCR demonstrated that 
 
z
 
50% of the
untreated neurons contained mRNA for MHC class I heavy chains, while, with few excep-
tions, the cells failed to transcribe 
 
b
 
2-microglobulin and TAP1/TAP2 gene transcripts. No
constitutive expression of MHC class I protein was detectable by confocal laser microscopy on
the surface of neurons.
All neurons transcribed the 
 
a
 
-chain of the interferon-type II receptor (binding IFN-
 
g
 
) along
with the p55 receptor for TNF-
 
a
 
. Sustained exposure to IFN-
 
g
 
 resulted in transcription of 
 
b
 
2-
microglobulin and TAP1/TAP2 genes and MHC class I surface expression in a minor part of
the neurons, but did not alter their electrophysiological activities as assessed by whole cell elec-
trophysiology. Suppression of neuronal electric activity by the sodium channel blocker tetro-
dotoxin drastically increased to almost 100% IFN-
 
g
 
-mediated induction of MHC class I chains,
of both TAP transporters, and of membrane expression of MHC class I protein. The effect of
tetrodotoxin is at least partly reverted by the neurotransmitter glutamate.
In contrast to IFN-
 
g
 
, treatment with TNF-
 
a
 
 did neither upregulate TAP1/TAP2 nor 
 
b
 
2-
microglobulin gene expression, but induced MHC class I heavy chain gene transcription in all
neurons. Consequently, no MHC class I molecules were detectable on the membranes of
TNF-
 
a
 
-treated neurons.
 
P
 
roinflammatory cytokines are known to functionally
connect the immune system with the central nervous
system (NS)
 
1
 
 during development and maturity. Observa-
tions mainly in tissue culture suggest that both IFN-
 
g
 
 and
TNF-
 
a
 
 affect the differentiation of neurons (1–3) or their
electric function (4–6). In the adult brain, proinflammatory
cytokines are known to profoundly influence behavioral
functions like sleep, feeding, and temperature regulation (7–9)
 
.
 
Furthermore, cytokines participate in the development of
pathological brain lesions. Both IFN-
 
g
 
 and TNF-
 
a
 
 are main
mediators in the pathogenesis of the inflammatory lesion in
autoimmune disease like multiple sclerosis. TNF-
 
a
 
 mediates
cytotoxic damage to glia cells and possibly neurons too, while
IFN-
 
g
 
 seems to act by inducing cell surface molecules re-
quired for interactions between immune and brain cells.
The brain’s complex structure makes it difficult to iden-
tify the cellular sources of locally produced cytokines, and
to follow their exact modes of action. Part of the cytokines
is released by autochthonous brain cells, while another part
comes from immune cells having invaded the CNS tissue, and
still another part of cytokines may enter the brain from out-
side through the endothelial blood–brain barrier or through
peripheral nerves. Once released into the brain tissue, cyto-
kines may act on neurons either directly, or via nonneu-
ronal brain cells.
In an attempt to better understand the action of proin-
flammatory cytokines on neurons, we combined patch clamp
electrophysiology with PCR gene amplification to study in
vitro the modulatory effect of IFN-
 
g
 
 and TNF-
 
a
 
 on MHC
class I gene expression in single, functionally matured neu-
rons. Using this paradigm, we recently described that cul-
tured hippocampal neurons are principally able to express
MHC class I genes, but that their own electric activity sup-
presses MHC inducibility (10). We now show that MHC
class I genes of neurons are differentially regulated by IFN-
 
g
 
1
 
Abbreviations used in this paper:
 
 BME, basal medium; CNS, central ner-
vous system; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GFAP,
glial fibrillary acidic protein; MAP2, microtubulin-associated-protein-2;
NS, nervous system.
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and TNF-
 
a
 
. IFN-
 
g
 
 was capable of inducing MHC class I and
MHC class I assembly-related genes in electrically paralyzed
neurons. In striking contrast, TNF-
 
a
 
 upregulated only MHC
class I heavy chain transcription, but did not induce TAP1/
TAP2 and 
 
b
 
2-microglobulin gene expression, irrespective
of electric membrane activity.
 
Materials and Methods
 
Hippocampal Cell Culture.
 
Mixed cell cultures were prepared
from hippocampus tissue of 18-d-old fetal Lewis rats, as previ-
ously described (11). After removal of meninges hippocampi
were dissected and dissociated by trituration through a fire-pol-
ished Pasteur pipette. Cells were plated on petri dishes which
have been coated with 0.5 mg/ml poly-
 
l
 
-ornithine (P 3530;
Sigma Chem. Co., St. Louis, MO). The culture medium was
composed of basal medium (BME, 41010-26; GIBCO BRL,
Gaithersburg, MD) enriched with 10% fetal calf serum (PanSys-
tems, Nürnberg, Germany). After 5–8 d the cells were cultured
under serum-free conditions in BME supplemented with bovine
serum albumin 100 
 
m
 
g/ml (A 7638; Sigma), transferrin 100 
 
m
 
g/ml
(T 5761; Sigma), insulin 5 
 
m
 
g/ml (I 6634; Sigma), progesterone
60 ng/ml (P 0130; Sigma), putrescine 16 ng/ml (P 7505; Sigma),
sodium selenite 40 ng/ml (S 1382; Sigma), thyroxin 40 ng/ml (T
1775; Sigma), triiodo-
 
l
 
-thyronine 30 ng/ml (T 6397; Sigma).
The cultures were incubated for at least 12 d before treatment
with recombinant rat IFN-
 
g
 
 (100 U/ml; Laboserv, Gießen, Ger-
many), recombinant human TNF-
 
a
 
 (10 ng/ml; Laboserv), tetro-
dotoxin (1 
 
m
 
M; Sigma), or 
 
l
 
-glutamate (2 
 
m
 
M; Sigma).
 
Immunofluorescence Labeling for Microtubulin-associated Protein 2 and
Glial Fibrillary Acidic Protein.
 
For immunofluorescence labeling
cells were fixed with 
 
2
 
20
 
8
 
C cold 95% ethanol plus 5% acetic acid
for 10 min. After blocking nonspecific binding sites with PBS plus
2% goat serum and 2% BSA the cells were labeled with mouse
mAb specific for microtubulin-associated-protein-2 (MAP2) (10
 
m
 
g/ml; Sigma) and rabbit polyclonal antibodies specific for glial
fibrillary acidic protein (GFAP) (10 
 
m
 
g/ml; Dako Diagnostika,
Hamburg, Germany) followed by secondary fluorochrome Cy3-
conjugated goat antibodies to mouse immunoglobulin (10 
 
m
 
g/ml;
Dianova) and fluorochrome (dichlorotriazinyl)aminofluorescein-
conjugated goat antibodies to rabbit immunoglobulin (10 
 
m
 
g/ml;
Dianova).
 
Immunofluorescence Labeling for IFN-
 
g
 
 Receptor and MAP2.
 
Cells
were fixed with 4% paraformaldehyde for 20 min and permeabi-
lized with Triton X-100 for 30 min. After treatment with phos-
phate buffered saline plus 2% goat serum and 2% bovine serum al-
bumin cells were labeled with rabbit polyclonal antiserum to
IFN-
 
g
 
 receptor 
 
a
 
-chain (binding to both rat and mouse re-
ceptors; 1 
 
m
 
g/ml, K-17; Santa Cruz Biotechnology, CA) fol-
lowed by secondary fluorochrome Cy3-conjugated goat antibod-
ies to rabbit immunoglobulin (10 
 
m
 
g/ml; Dianova). Neurons were
double-labeled with mouse monoclonal antibodies specific for
MAP2 (10 
 
m
 
g/ml; Sigma) followed by secondary fluorochrome
(dichlorotriazinyl)aminofluorescein-conjugated goat antibodies to
mouse immunoglobulin (10 
 
m
 
g/ml; Dianova). Background label-
ing was monitored with the synthetic peptide used as immunogen
(2 
 
m
 
g/ml, K-17; Santa Cruz Biotechnology) plus the polyclonal
antiserum to IFN-
 
g
 
 receptor and secondary fluorochrome Cy3-
conjugated goat antibodies to rabbit immunoglobulin.
 
Patch–Clamp Electrophysiology.
 
Neuronal activity was analyzed
in single hippocampal cells using the whole cell recording config-
uration of the patch–clamp technique (12). The pipettes were
pulled from borosilicate glass to wide tip openings giving resis-
tances of 2–5 
 
V
 
M. The pipette filling solution contained: 135 mM
KCl, 4 mM MgCl
 
2
 
, 1 mM EGTA, 5 mM Hepes (pH 7.3). Dur-
ing the recordings the cells were bathed in a solution containing:
135 mM NaCl, 2 mM CaCl
 
2
 
, 2 mM MgCl
 
2
 
, 5 mM KCl, 5 mM
Hepes (pH 7.3). The resting potential and spontaneous action po-
tentials were monitored in the current clamp mode. Additionally,
single action potentials were elicited from 
 
2
 
60 mV by current
pulses of 200–400 pA and a duration of 2.5 ms. Membrane cur-
rents were recorded in the voltage clamp mode with ramps (0.5
mV/s) from 
 
2
 
80 to 
 
1
 
80 mV delivered from a holding potential
of -80 mV to allow a semiquantitative estimate of sodium and po-
tassium currents. 
 
Single Cell RT-PCR.
 
A modified single cell RT-PCR was
performed as described (13). To destroy RNA-degrading en-
zymes all glass tubes and the silver wire were baked for 4 h at
220
 
8
 
C. Neurons were identified on the basis of spontaneous or
evoked action potentials. Cytoplasm was sampled after electro-
physiological recordings by applying negative pressure to the mi-
cropipette. Samples of the extracellular fluid and pipette solution
served as controls and collection was controlled visually under the
microscope. After removing the pipette, positive pressure was ap-
plied to the pipette and the tip of the pipette was broken in a test
tube containing dithiothreitol (10 mM; GIBCO BRL), ribonu-
clease inhibitor (20 U; Promega Corp., Madison WI), hexamer
random primers 1 
 
m
 
l (Boehringer Mannheim, Mannheim, Ger-
many) and the four deoxyribonucleotides triphosphate (0.5 mM;
Pharmacia). Moloney murine leukemia virus reverse transcriptase
(100 U; GIBCO BRL) was added to the test tube. The resulting
10 
 
m
 
l mix was incubated for 1 h at 42
 
8
 
C. Single stranded cDNA
was then stored at 
 
2
 
80
 
8
 
C. Cytoplasmic mRNA of individual CD4
pos. myelin basic protein-specific T-lymphoblasts (14) was col-
lected through a patch–clamp pipette and was reverse transcribed
similarly. Total brain and thymus RNA was isolated using RNAzol
(Wak-chemie, medical GmbH, Bad Homburg, Germany) (15) and
was reverse transcribed as described. Brain- and thymus-derived
tissue cDNA was diluted to a concentration of 20 pg/
 
m
 
l.
To avoid false positive PCR amplification special precautions
were taken as described (16). Oligonucleotide sequences were se-
lected with the program PRIMER (Whitehead Institute, MIT,
Cambridge). Forward and reverse primers were always chosen
from two different exons to detect a possible amplification of nu-
clear DNA. The respective primer pairs were for rat glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) (GenBank-EMBL acces-
sion number X02231): 5
 
9
 
-CCCACGGCAAGTTCAACGG-3
 
9
 
(pos. 220 to 238); 5
 
9
 
-CTTTCCAGAGGGGCCATCCA -3
 
9
 
(pos.
647 to 628), for rat 
 
b
 
2-microglobulin (accession number Y00441):
5
 
9
 
-CGGTGACCGTGATCTTTCTGGT-3
 
9
 
(pos. 18 to 39);
5
 
9
 
-GGTGACGGTTTTGGGCTCCTT-3
 
9
 
 (pos. 349 to 329),
for Lewis rat MHC class I (accession number L26224): 5
 
9
 
-TGC-
AGAGAGACTCAGGGCCTACC-3
 
9
 
(pos. 537 to 559); 5
 
9
 
-TGC-
CAGCTCAGGGAGATGTCA-3
 
9
 
 (pos. 734 to 714), for TAP1/
MTP-1 (accession number X57523): 5
 
9
 
-CCTCCATGCAGA-
AGTCCGTGG-3
 
9
 
(pos. 1375 to 1395); 5
 
9
 
-CATCCAGGA-
GCACCTTGCCC-3
 
9
 
(pos. 1674 to 1655), for Lewis rat TAP2/
MTP2 (accession number X75305): 5
 
9
 
-TGCTGTATCAGGAG-
GAAGTGGGG-3
 
9
 
 (pos. 1274 to 1296); 5
 
9
 
-AAGCGGTCAC-
CTTTCCAGGATG-3
 
9
 
 (pos. 1537 to 1516), for GFAP (accession
number L27219): 5
 
9
 
-AAGCTCCAAGATGAAACCAACC-
TGA-3
 
9
 
 (pos. 459 to pos. 483); 5
 
9
 
-CCACGATGTTCCTC- 
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TTGAGGTGG-3
 
9
 
 (pos. 1227 to 1205), for MAP2 (accession
number X51842): 5
 
9
 
-AGCCTGCAGCTCTGCCTTTAGC-3
 
9
 
(pos. 415 to 436); 5
 
9
 
-AGGTCTGGCAGAGGTTGGTTAA-
TGA-3
 
9
 
 (pos. 5077 to 5053), for mouse IFN-
 
g
 
 receptor (accession
number M28995): 5
 
9
 
-GGTTGGACAAAAAGAATCTGACT-
ATGC-39 (pos. 339 to 366); 59-GCACTTTTTACCACA-
GAGAGCAAGGAC-39 (pos. 908 to 882), for TNF-a receptor
(accession number M63122): 59-CCCAGGACTCAGGTACT-
GCCGT-39 (pos. 851 to pos. 872); 59-CAGAGTGGGGTTG-
AAGCCGG-39 (pos. 1092 to pos. 1073), for calnexin (accession
number L18889): 59-TGGGGCCTGAAGAAAGCTGCTG-39
(pos. 1366 to 1387); 59-CGTCCTTCACATCTGGCTGGGG-39
(pos. 1582 to 1561). All oligonucleotides were synthesized at the
Max-Planck-Institute for Biochemistry (Martinsried, Germany).
b2-microglobulin and MHC class I mRNA was amplified si-
multaneously with GAPDH as internal standard (multiplex PCR).
All other gene transcripts were coamplified along with GAPDH
in separate reaction tubes. The reaction was done in a final vol-
ume of 50 ml containing 1 ml of the transcribed cDNA probe, the
four deoxyribonucleotide triphosphates (0.2 mM each, Pharma-
cia), 2.5 U Ampli Taq (Perkin-Elmer/Cetus, Norwalk, CT) and
13 PCR-buffer (Perkin-Elmer/Cetus) covered with two drops
of mineral oil (M 3516; Sigma). PCR amplification was per-
formed on a programmable thermocycler (MultiCycler PTC 200;
MJ Research Inc., Watertown, MA). After the cDNA was dena-
turated at 958C for 3 min denatured primers (final 100 pmol
primers) were added to each tube at 808C. Polymerase chain re-
action was performed by 48 cycles (938C for 1 min; ramp with
0.18C/s from 938C to 608C; 608C for 1 min; 728C for 1 min) and
followed by one final cycle at 728C for 5 min. 10 ml of the PCR
reaction was loaded in parallel with the molecular weight marker
(FX 174, HaeIII digested; Pharmacia) on a 1.7% agarose gel con-
taining ethidium bromide.
Restriction Site Analysis and Sequencing. For restriction site anal-
ysis PCR products (10 ml) from multiplex PCR were digested at
378C for one hour. BglI, BglII and ApaI (10 U; Boehringer Mann-
heim) were chosen to cut the PCR fragments of GAPDH, b2-
microglobulin and MHC class I, respectively. StuI and RsaI (10 U;
Boehringer Mannheim) were chosen to cut PCR fragments of
TAP1 and TAP2, respectively. The digested DNA fragments were
analyzed by agarose gel electrophoresis as described above. PCR
products were purified from ethidium bromide stained agarose gels
using the gel extraction method (Qiax gel extraction kit; Qiagen,
Chatsworth, CA) and directly sequenced with an automated se-
quence analyzer (Perkin Elmer/Applied Biosystems 373A).
Confocal Laser Scanning Microscopy. Mixed hippocampal cell cul-
tures were treated as indicated with 100 U/ml IFN-g or 10 ng/ml
TNF-a and were labeled with monoclonal anti MHC class I an-
tibody Ox 18 by adding 10 mg/ml antibody (final; Serotec Ltd.,
Oxford, UK) to the cell culture for 30 min. Cells were washed
with phosphate buffered saline and fixed with 4% paraformalde-
hyde. After blocking with 2% goat serum and 2% BSA in PBS
cells were incubated with secondary fluorochrome Cy3-conju-
gated goat antibodies specific for mouse immunoglobulin (10 mg/
ml; Dianova). To identify neurons, cells were permeabilized with
0.1% Triton X100 and stained with mouse monoclonal antibod-
ies specific for MAP2 (10 mg/ml; Sigma) and secondary fluoro-
chrome (dichlorotriazinyl) aminofluorescein-conjugated goat anti-
bodies to mouse immunoglobulin (10 mg/ml; Dianova). 10 optical
sections along the z-axis were scanned with a confocal laser scan-
ning microscope (Leica Inc., Deerfield, IL) equipped with a 63
oil objective. Baseline labeling was revealed with isotype-matched
monoclonal antibodies and secondary fluorochrome Cy3-conju-
gated goat antibodies to mouse immunoglobulin.
Results
Identification of Electrically Active Neurons. Cells dissociated
from fetal rat hippocampal tissue (E18) were allowed to dif-
ferentiate for up to 2 wk. By day 12 in culture the neuronal
cells formed a network of dense processes placed on top of
an astrocyte monolayer (Fig. 1, A–C). Individual neurons
were selected morphologically and identified by whole cell
patch–clamp recording of spontaneous or evoked fast ac-
tion potential firing (Fig. 2). Immediately after electrophys-
iological analysis, samples of cytoplasm were drawn from
the recorded cell through the micropipette. Messenger-
RNA of each single cell was reversely transcribed into
cDNA and analyzed after PCR amplification with specific
primers. Efficiency and specificity of the patch-clamp RT-
PCR method was verified by co-amplifying housekeeping
and lineage-specific gene transcripts. These included GAPDH
as housekeeping gene, along with the cytoskeleton proteins
MAP2 specific for neurons, and GFAP for astrocytes, the
most important non-neuronal cells present in the cultures.
Fig. 1 D displays the correct transcription of the lineage
specific gene markers in a series of selected neurons and as-
trocytes, respectively. MAP2, but not GFAP, was exclu-
sively detected in neuron-derived material, while all sam-
ples from neighboring astrocytes yielded solely cDNA for
GFAP.
MHC Class I–related Gene Transcription in Single, Untreated
Neurons. Single cell RT-PCR was performed to examine
the transcription of MHC class I heavy chain, b2-micro-
globulin, TAP1/TAP2 and calnexin genes in individual neu-
rons in the absence of exogenous cytokines or modulatory
agents. Transcripts of the MHC class I heavy chain binding
protein calnexin gene were present in all analyzed hippo-
campal neurons (Fig. 4 A), while 12 out of 22 analyzed
neurons contained MHC class I heavy chain mRNA (Fig.
3, Tables 1 and 2). In contrast, mRNA for b2-microglobulin
was rarely detectable (2 of 22 cells) and TAP1/TAP2 tran-
scripts were absent in all (0/22) analyzed neurons. In con-
trast, the same single cell RT-PCR technique, when ap-
plied to activated T-lymphocytes, detected MHC class I,
b2-microglobulin and TAP1/TAP2 mRNA in all cells
(Fig. 3, Table 1). In astrocytes we persistently amplified MHC
class I heavy chain and b2-microglobulin genes, although
TAP1 and TAP2 gene transcripts were detectable only in
some, but not all astroglial cells (6/10 and 5/10, respectively).
Expression of Receptors for IFN-g and TNF-a in Neurons.
There is clear evidence that proinflammatory cytokines can
modulate neuronal function, but it has remained open,
whether the cytokines act directly on the neurons, or indi-
rectly, via local glial cells. We examined cultured untreated
neurons for expression of receptors for IFN-g and TNF-a,
prerequisites of direct cytokine effects. Transcripts for the
IFN-g receptor a-chain were detected in 8/8 neurons ana-
lyzed (Fig. 4 B). The sequence of the amplified rat IFN-g308 MHC Class I Gene Expression in Single Neurons
receptor PCR-product (submitted to GenBank, accession
number U 68272) was homologous (83%) to the IFN-g
receptor sequence of the mouse, and in agreement with
transcripts amplified from peripheral lymph organs. To cor-
roborate IFN-g expression in hippocampal neurons we per-
formed immunofluorescence labeling of the IFN-g receptor.
IFN-g receptor a-chain immune reactivity was detectable
in neurons as well as in glial cells (Fig. 5). Almost all of hip-
pocampal neurons identified by MAP2 staining (98 6 3%,
mean 6 SEM) were labeled with antibodies to the IFN-g
binding receptor.
Further, transcripts for the rat 55 kD TNF receptor were
detected in all (9/9) hippocampal neurons analyzed (Fig. 4 C).
Effect of IFN-g on Neuronal Transcription and Surface Ex-
pression of MHC Class I Protein. Treatment with 100 U/ml
IFN-g for 72 h did not interfere with the bioelectric activ-
ities of hippocampal neurons. We measured resting poten-
tials to assess the functional integrity of hippocampal neu-
rons treated with IFN-g. Typically, the resting potential of
IFN-g-treated neurons was 67.4 6 4.6 mV (mean 6 SE, n 5
28) and was not statistically different from control cells
(69.3 6 5.7 mV, n 5 17). IFN-g-treated neurons also
spontaneously fired action potentials (Fig. 2 B), like control
neurons (Fig. 2 A). Neurons treated with IFN-g, displayed
various types of firing patterns like bursts or periodic single
action potentials, which were likewise observed in control
cells.
We examined the effect of IFN-g on the expression of
MHC class I–related genes by exposing neuronal cultures
for 24 to 72 h to 100 U/ml IFN-g. This treatment did not
cause profound changes. Comparable to untreated cultures,
IFN-g treatment for 24 h resulted in the transcription of
Figure 1. Neuronal cell culture and lineage specific single cell RT-PCR. Neurons from embryonic hippocampi differentiated on top of a monolayer
of astrocytes (A). Double immunofluorescence labeling for cell lineage-specific cytoskeletal markers MAP2 for neurons (B) and GFAP for astrocytes (C).
Gene transcripts for MAP2 and GFAP amplified by single-cell patch–clamp RT-PCR from individual neurons (lanes 1–3) and astrocytes (lanes 4–6) on
ethidium bromide stained agarose-gel (D). Lane N and lane M show negative controls of PCR-amplification and molecular weight marker X174/Hae
III, respectively. Bar, (A–C) 20 mm.309 Neumann et al.
MHC class I heavy chain mRNA in 13/20 neurons, while
b2-microglobulin transcripts were detected in 7/20 neu-
rons and TAP1 and TAP2 transcripts in 5 out of 20 neu-
rons respectively (Fig. 6 A, Table 2). Remarkably, only 3
out of 20 neurons transcribed all four genes at the same
time. The proportion of class I gene transcribing neurons
remained essentially stable throughout a IFN-g treatment
period of 72 h.
IFN-g-induced transcription of class I genes in neurons
was, however, dramatically increased by the blockade of
sodium channels by tetrodotoxin (TTX). After 72 h treat-
ment with TTX plus IFN-g all neurons expressed MHC
class I heavy chain, b2-microglobulin (19/19), and almost
all expressed TAP1 (18/19) and TAP2 (17/19) gene tran-
scripts (Fig. 6 B, Table 2). Restriction fragment analysis and
sequencing confirmed the identity of the amplified PCR
fragments (Fig. 7 A). 
The enhancing effect of TTX treatment was neutralized
by the neurotransmitter l-glutamate. Application of 2 mM
glutamate to cultures treated with IFN-g plus TTX re-
duced transcription of MHC class I related genes to base-
line levels of untreated neurons (Table 2). In the presence
Figure 2. Spontaneous bioelec-
tric activity of hippocampal neurons
with or without IFN-g treatment.
(A) Spontaneous firing of action
potentials persisting over at least 10
min by an untreated neuron (upper
trace). Additional suprathreshold
current pulses elicited single action
potentials (lower trace, left). Depola-
rising ramps demonstrated sodium
and potassium currents, downward
and upward deflections, respec-
tively (lower trace, right). (B) Hip-
pocampal neuron treated with
IFN-g (100 U/ml) for 3 d. 310 MHC Class I Gene Expression in Single Neurons
of glutamate only very few neurons were induced by IFN-g
and TTX to transcribe MHC class I heavy chain or b2-
microglobulin and none of the neurons transcribed TAP1/
TAP2 genes, whereas expression of the housekeeping gene
GAPDH was not affected by the transmitter. 
Membrane expression of MHC class I protein was stud-
ied by confocal laser scanning microscopy after double im-
munofluorescence labeling of live neurons combining mono-
clonal antibodies against MHC class I molecules with neuron
specific marker antibodies. There was no constitutive expres-
sion of MHC class I molecules on the surface of untreated
hippocampal neurons. Treatment with 100 U/ml IFN-g
for 72 h, however, resulted in MHC class I expression on
the cell surface in 34% of the hippocampal neurons (Figs. 8
and 9 A). MHC class I molecules accumulated on the cell
surface by IFN-g steadily with the duration of treatment
(Fig. 9 B).
After treatment with IFN-g plus TTX, 91 % of the neu-
rons were induced to express MHC class I protein, and this
increased expression was neutralized by the additional ap-
plication of glutamate. After triple treatment with IFN-g,
TTX and glutamate only 32% of the hippocampal neurons
expressed MHC class I products (Fig. 9 A). To significantly
enhance MHC class I expression, TTX had to be present in
the cultures for a minimum of 48 h.
Effect of TNF-a on Neuronal MHC Class I Expression.
Treatment of hippocampal neurons with 10 ng/ml TNF-a
for 72 h did not result in overt changes of their electrophys-
iological parameters. Resting potential of TNF-a-treated
neurons was 68.3 6 7.8 mV (mean 6 SE, n 5 19) and thus
was in the range of control untreated cells (65.3 6 7.4 mV,
n 5 21). Frequency and firing patterns of action potentials
Figure 3. Gene transcripts for GAPDH, b2-microglobulin, MHC class I
heavy chain, and TAP1/TAP2 amplified from individual neurons and ac-
tivated T cells. Cytoplasmic mRNA samples of individual neurons (lanes
1–5) and of individual T lymphoblasts (lanes 6 and 7) collected from sin-
gle cells using the patch–clamp micropipette, reversely transcribed and co-
amplified by multiplex PCR with specific primers for GAPDH, b2-
microglobulin and MHC class I heavy chain (A). Whole brain tissue
cDNA (lane B) and whole thymus tissue cDNA (lane T) as positive con-
trols. Parallel coamplification of the same cDNA samples to detect TAP1
(B) and TAP2 (C) gene transcripts. Neurons (lanes 1–4), T lymphoblasts
(lanes 5 and 6) or whole brain (lane B) and thymus tissue (lane T). Lane N
and lane M show negative controls of PCR amplification and molecular
weight marker X174/Hae III, respectively.
Figure 4. Gene transcripts for calnexin, IFN-g-receptor a-chain and
TNF-a-receptor p55 amplified from individual neurons. Hippocampal
neurons (lanes 1–6) expressing gene transcripts for calnexin (A), for IFN-
g-receptor a-chain (B) and for TNF-a-receptor p55 (C). Lanes N and M
show negative control of PCR-amplification and molecular weight
marker X174/Hae III, respectively.
Table 1. Gene Transcripts for MHC Class I Heavy Chain, 
b2-Microglobulin and TAP1/TAP2 Detected in Single Cells
Cell type
Cells expressing mRNA for
MHC I b2m TAP1 TAP2
Neurons 40% 10% 0% 0%
4/10 1/10 0/10 0/10
T cells 100% 100% 100% 100%
5/5 5/5 5/5 5/5
Astrocytes 100% 100% 60% 50%
10/10 10/10 6/10 5/10311 Neumann et al.
of TNF-a-treated cells were indistinguishable from un-
treated hippocampal neurons.
TNF-a affects MHC class I related gene expression in a
very restricted pattern. Within 24 h of treatment, the cy-
tokine induced MHC class I heavy chain mRNA transcrip-
tion in 14/15 neurons, and within 72 h in 20/20 hippo-
campal neurons (Fig. 7 B, Table 3). Remarkably, however,
under the same conditions there was scarcely any concomi-
tant enhanced transcription of b2-microglobulin, or TAP1/
TAP2 genes. Even more unexpected, additional treatment
of neurons with TTX completely failed to enhance TNF-
a-mediated induction of TAP1/TAP2 (0/11 and 0/11)
and b2-microglobulin (1/11) genes (Table 3). Finally,
MHC class I molecules were not detectable on neuronal
cells surfaces after treatment with TNF-a alone, TTX
alone or their combination (Fig. 9 A). 
Discussion
This work studied the effect of two key proinflammatory
cytokines, IFN-g and TNF-a, on induction of MHC class I
molecules in functionally intact neurons grown in cultures
of dissociated embryonic rat hippocampus cells. This cul-
ture system proved especially useful for our studies, because
it allows embryonic neurons to differentiate to a remark-
able degree of maturity, as indicated by their morphological
and electrophysiological properties. However, to reach this
stage of differentiation, the neurons critically depend on
the presence of a supportive monolayer of astrocytes. In
mixed CNS cultures, it is difficult to distinguish between
neuronal and glial gene expression. Hence, many investiga-
Figure 5. IFN-g receptor im-
munoreactivity in hippocampal
neurons. Double immunofluo-
rescence for IFN-g receptor
a-chain (A), MAP-2 (B) and
phase contrast (C). Scale bar:
20  mm.
Neurons pretreated with IFN-g (100 U/ml) for 72 h. Gene transcripts for
MHC class I heavy chain, b2-microglobulin (b2-m) and GAPDH co-
amplified in multiplex from individual neurons (lanes 1–10). Gene tran-
scripts for TAP1 and TAP2 coamplified in parallel from the same neuron
derived samples. Lanes N and M show negative control of PCR-ampli-
fication and molecular weight marker FX174/Hae III, respectively.
Neurons pretreated with IFN-g plus TTX for 72 h. Lane arrangement
like in A.
Figure 6. Induction of MHC class I heavy chain, b2-microglobulin
and TAP1/TAP2 gene transcripts in individual neurons by IFN-g. (A)312 MHC Class I Gene Expression in Single Neurons
tions of neuronal MHC class I gene transcription were per-
formed using clonally pure transformed neuronal cells (17–
19). However, interpretation of these data must take into
account possible altered MHC class I gene regulation in the
transformed cells (20). To distinguish neuronal from glial
gene expression in mixed primary brain cultures we applied
patch clamp electrophysiology (which identified nature and
state of activity of a neuron) combined with RT-PCR of
single cultured cells. This method, first described by Lam-
bolez et al. (13), allows the correlation of electrical mem-
brane activity of a cell with its actual gene expression pat-
tern. Because of its high sensitivity, this technology requires
rigorous controls of specificity (21). Apart from standard
PCR controls, we included in our studies the amplification
of positive and negative cell lineage markers. Indeed, cells
which were characterized electrophysiologically as neurons
contained mRNA for MAP2, a cytoskeletal marker specific
for neurons, while samples from astrocytes contained mRNA
for GFAP, but not MAP2. 
Our study of direct cytokine effects on cultured neurons
rested on the assumption that these neurons indeed express
functional cytokine receptors. To verify this point, we ap-
plied primers selecting for cDNA of the chain of the rat
IFN-g receptor and for the p55 chain of the TNF-a recep-
tor. In all cytoplasmic samples we found the classic rat p55
TNF-a receptor sequence (22), which is in accord with a
previous report describing TNF-a receptor p55-like im-
munoreactivity in cultured rat hippocampal neurons (23).
In contrast, the sequences of the rat IFN-g receptor was
not found in our accessible data bases. Using specific prim-
ers derived from the known mouse sequence we amplified
from all neurons a sequence sharing 83% homology with
the mouse and 66% homology to the human IFN-g recep-
tor chains, respectively. Identical PCR products were am-
plified from peripheral lymphoid tissues, which are known to
express the classic IFN-g receptor. Surface expression of
the IFN-g receptor a-chain in hippocampal neurons was
confirmed by immunocytochemistry.
Stable surface expression of MHC class I molecules re-
quires correct assembly of three components, the class I
heavy chain (45-kD membrane anchored glycoproteins),
the b2-microglobulin, and the antigenic peptides which
are embedded in a groove formed by the heavy chain (24).
Most peptides are derived from cytosolic proteins, which
are degraded by proteasomes. MHC-linked TAP1/TAP2
peptide transporters translocate the peptides to the endo-
plasmic reticulum where they displace calnexin from the
nascent class I complex (25). Our study of neuronal class I
expression included the genes for the class I heavy chain
and the TAP transporters, which are all contained within
the MHC, along with independently located b2-microglo-
bulin and calnexin genes.
Table 2. Induction of MHC Class I Heavy Chain, 
b2-Microglobulin and TAP1/TAP2 mRNA by IFN-g and
TTX in Single Neurons (TTX 1 mM, IFN-g 100 U/ml,
Glu.2 mM Glutamate)
Treatment
Neurons expressing mRNA for
MHC I b2m TAP1 TAP2
No 55% 9% 0% 0%
12/22 2/22 0/22 0/22
TTX, 24 h 75% 13% 0% 0%
6/8 1/8 0/8 0/8
TTX, 72 h 92% 17% 0% 0%
11/12 2/12 0/12 0/12
IFN-g, 24 h 65% 35% 25% 25%
13/20 7/20 5/20 5/20
IFN-g, 72 h 71% 43% 24% 19%
15/21 9/21 5/21 4/21
IFN-g, 24 h 1
TTX, 24 h 80% 55% 40% 35%
16/20 11/20 8/20 7/20
IFN-g, 72 h 1
TTX, 72h 100% 100% 95% 90%
19/19 19/19 18/19 17/19
IFN-g, 72 h 1
TTX, 72h 1
Glut., 72 h 55% 27% 0% 0%
6/11 3/11 0/11 0/11
Figure 7. Restriction site analysis of amplified PCR-fragments and
MHC class I heavy chain induction by TNF-a. (A) PCR-fragments am-
plified from IFN-g plus TTX treated individual neurons, digested by re-
striction enzymes selected from the published sequence. PCR-fragments
for GAPDH (428 bp) cut into 324 bp and 104 bp, for b2-microglobulin
(332 bp) into 206 bp and 126 bp, for MHC class I heavy chain (198 bp)
into 160 bp and 38 bp. PCR-fragments for TAP1 (300 bp) cut into 194
bp and 106 bp. PCR-fragments for TAP2 (264 bp) cut into 192 bp and
72 bp. All analyzed PCR-fragments were in agreement with the pub-
lished sequences. (B) Gene transcripts for GAPDH, b2-microglobulin and
MHC class I heavy chain coamplified from individual neurons (lanes 1 to
10) treated for 72 h with TNF-a. Lane N and lane M show negative con-
trol of PCR-amplification and molecular weight marker FX174/Hae III,
respectively.313 Neumann et al.
We found that neuronal expression of MHC class I genes
differs significantly from gene expression in other cells. Al-
though intact neurons fail to express MHC class I determi-
nants on their membranes, a significant proportion of the cells
transcribe class I heavy chains, but not the other class I–related
genes. Thus, in contrast to other cells (26), class I protein
expression in neurons is not limited by the synthesis of
heavy chains, but by b2-microglobulin and TAP1/TAP2
peptide transporter genes. This is reminiscent of tumors
which lack membrane MHC class I expression due to a
deficit of available b2-microglobulin (27) or TAP2 trans-
porters. IFN-g treatment induces class I–related genes in
some but not in all cultured neurons (quantification of gene
transcription in individual cells was, however, not feasible
using our technology). Paralysis of neurons with TTX,
leads to a dramatic induction of all class I–related genes and
protein expression in all neurons.
In contrast to IFN-g, TNF-a acts exclusively on class I
heavy chain transcription, and, as reported by Israel et al.
(28), does not affect expression of b2-microglobulin. This
is in line with previous studies showing that the two genes
are separately and differentially regulated in some tissues
and during development (29). In contrast, transformed hu-
man neuroblastoma lines responded to both cytokines with
enhanced transcription of class I heavy chain and b2-micro-
globulin (18). In human endothelial cell cultures, membrane
expression of MHC class I protein is readily induced both
by IFN-g and by TNF-a (30), both cytokines acting via dis-
tinct activation pathways (31). Our data indicates that TNF-a
alone is not sufficient to induce TAP1/TAP2 genes despite
the fact that in humans and rodents, the described TAP1 gene
promoter sequence includes an NFkB binding site (32).
Of special interest is the downregulatory effect of neural
electric activity on cytokine induced class I gene expres-
sion. Electric membrane activity exerts manifold effects on
gene expression, as revealed by numerous studies of cul-
tured rodent neurons. For example, neuronal activity con-
trols production of synaptic receptor isoforms (33, 34), syn-
Figure 8. MHC class I molecules
on the neuronal cell surface. Confo-
cal laser scanning microscopy of
MHC class I molecules located on
the cell surface. Identification of in-
dividual neurons (pretreated with
IFN-g for 72 h) by counterlabeling
the neuron-specific cytoskeleton
protein MAP2. MHC class I mole-
cules labeled red (A) and MAP2
green (B). Merger of both images
from one optical section with spe-
cific labeling of MHC class I mole-
cules on the neuronal cell surface
(C). D and E show one neuron
with, and another one without
MHC class I cell surface labeling.
Scale bar: (A–C) 10 mm; (D and E)
20 mm.314 MHC Class I Gene Expression in Single Neurons
thesis of neurotrophins (35), and their receptors (36) and
cell adhesion molecules (37, 38), and thus contributes to neu-
ronal plasticity, the structural basis of learning and memory. 
We found that the effect of TTX on MHC inducibility
is reversed by activation of glutamate receptors. This, how-
ever, does not necessarily imply neurotransmitters as sole
mediators involved in activity-dependent regulation of MHC
class I expression. It is not even known, whether MHC class I
gene control implies cell-to-cell interactions i.e., whether
exogenous signals are required for a cell to suppress class I
gene transcription, or whether electric membrane activity
acts on gene expression within the same cell. In neurons,
activity-dependent gene induction is predominantly gov-
erned by modulation of topical calcium concentration
which can be brought about through activation of calcium
channels to import extracellular calcium, or by release from
intracellular calcium stores. Depending on location and
levels, changes of calcium levels may result in radically dif-
ferent effects on gene expression (39). Although not for-
mally proven in our work, it appears reasonable to assume
that calcium also has a pivotal role in connecting mem-
brane activity depending and cytokine mediated regulation
of neuronal MHC class I expression. Distinct effects of cal-
cium on IFN-g signaling, and on TNF-a signal transduc-
tion pathways may be responsible for the distinct and char-
acteristic effects of both cytokines on neuronal MHC class I
expression. Indeed, both signaling pathways are workable in
neurons, as shown recently for JAK/Stat1 and IFN-g (Neu-
mann, H., unpublished results) and signs of NFkB activation
(40) which can be augmented by TNF-a (41).
In their entirety, our results reveal unexpected effects of
two major proinflammatory cytokines on MHC class I
gene expression in electrically active CNS neurons. The
findings shed light on the cellular organization of immune
reactivity within the brain, and, in addition, may help to
better understand the impact of electric membrane activity
on cellular gene expression.
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Figure 9. Inducibility of MHC class I molecules on the neuronal cell
surface. Percentage of MHC class I surface expressing neurons (mean plus
SEM) as identified by confocal laser scanning microscopy (MAP2 as neu-
ronal marker). (A) Number of MHC class I expressing neurons after 72 h
treatment with IFN-g (100 U/ml), TNF-a (10 ng/ml), TTX (1 mM)
and/or glutamate (Glu.; 2 mM). (B) Induction of MHC class I surface ex-
pression on neurons treated with IFN-g with or without TTX over time
(24–96 h).
Table 3. Induction of MHC Class I Heavy Chain mRNA by 
TNF-a in Single Neurons (TNF-a 10 ng/ml, TTX 1 mM)
Treatment
Neurons expressing mRNA for
MHC I b2m TAP1 TAP2
TNF-a, 24 h 93% 13% 0% 0%
14/15 2/15 0/15 0/15
TNF-a, 72 h 100% 15% 0% 0%
20/20 3/20 0/20 0/20
TNF-a, 24 h 1
TTX, 24 h 100% 0% 0% 0%
9/9 0/9 0/9 0/9
TNF-a, 72 h 1
TTX, 72 h 100% 9% 0% 0%
11/11 1/11 0/11 0/11315 Neumann et al.
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